...
首页> 外文期刊>Glycoconjugate journal >Immunization of A4galt-deficient mice with glycosphingolipids from renal cell cancers resulted in the generation of anti-sulfoglycolipid monoclonal antibodies
【24h】

Immunization of A4galt-deficient mice with glycosphingolipids from renal cell cancers resulted in the generation of anti-sulfoglycolipid monoclonal antibodies

机译:用来自肾细胞癌的糖鞘脂对A4galt缺陷小鼠进行免疫导致产生抗磺基糖脂单克隆抗体

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we immunized Gb3/CD77 synthase gene (A4galt) knockout (KO) mice with glycosphingolipids (GSLs) extracted from 3 renal cell cancer (RCC) cell lines to raise monoclonal antibodies (mAbs) reactive with globo-series GSLs specifically expressed in RCCs. Although a number of mAbs reactive with globo-series GSLs were generated, they reacted with both RCC cell lines and normal kidney cells. When we analyzed recognized antigens by mAbs that were specifically reactive with RCC, but not with normal kidney cells at least on the cell surface, many of them turned out to be reactive with sulfoglycolipids. Eight out of 11 RCC-specific mAbs were reactive with SM2 alone, and the other 3 mAbs were more broadly reactive with sulfated glycolipids, i.e. SM3 and SM4 as well as SM2. In the immunohistochemistry, these anti-sulfoglycolipids mAbs showed RCC-specific reaction, with no or minimal reaction with adjacent normal tissues. Thus, immunization of A4galt KO mice with RCC-derived GSLs resulted in the generation of anti sulfated GSL mAbs, and these mAbs may be applicable for the therapeutics for RCC patients.
机译:在这项研究中,我们用从3种肾细胞癌(RCC)细胞系中提取的糖鞘脂(GSL)免疫了Gb3 / CD77合酶基因(A4galt)敲除(KO)小鼠,以提高与特异性表达球蛋白系列GSL的反应性的单克隆抗体(mAb)在RCC中。尽管产生了许多与球系列GSL反应的mAb,但它们与RCC细胞系和正常肾细胞均发生了反应。当我们通过与RCC有特异性反应但至少与正常肾细胞至少在细胞表面不具有反应性的mAb分析识别的抗原时,发现其中许多与磺基糖脂具有反应性。 11个RCC特异性mAb中有8个仅与SM2反应,其他3个mAb与硫酸化糖脂,即SM3和SM4以及SM2具有更广泛的反应性。在免疫组织化学中,这些抗磺基糖脂单克隆抗体显示出RCC特异性反应,与相邻正常组织无反应或反应极少。因此,用RCC衍生的GSL免疫A4galt KO小鼠可产生抗硫酸化的GSL mAb,这些mAb可用于RCC患者的治疗。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号